相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- FNCLCC
- 入组人数
- 94
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced TumorsAdvanced Malignant TumorsMedDRA version: 21.0Level: LLTClassification code: 10048683Term: Advanced cancer Class: 10029104CTIS2023-508280-69-00Bristol Myers Squibb International Corporation112
进行中（未招募）
1 期
A Phase 1b study of inhaled RCT1100 in Adults with Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary ClearanceCTIS2023-510521-14-00Recode Therapeutics Inc.12
进行中（未招募）
1 期
A study to test how kidney problems influence the blood concentrations of efgartigimodrenal impairmentCTIS2023-503992-88-00Argenx48
招募中
1 期
Safety and Tolerability of AC01 in patients with heart failureMedDRA version: 20.0Level: LLTClassification code: 10078289Term: Heart failure with reduced ejection fraction Class: 10007541Heart FailureCTIS2022-500347-20-00Anacardio AB116
招募中
1 期
A Phase I study of STA551 and STA551 in combination with atezolizumab in patients with solid tumoursocally advanced or metastatic solid tumorsMedDRA version: 21.1Level: PTClassification code: 10028997Term: Neoplasm malignant Class: 100000004864CTIS2023-508764-30-00Chugai Pharmaceutical Co. Ltd.150